1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid has been researched along with Atherogenesis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Binderup, T; Christensen, E; Døssing, KBV; Khare, HA; Kjaer, A; Pedersen, SF; Ringgaard, L; Ripa, RS; Sillesen, H; Urbak, L | 1 |
1 other study(ies) available for 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid and Atherogenesis
| Article | Year |
|---|---|
In vivo detection of urokinase-type plasminogen activator receptor (uPAR) expression in arterial atherogenesis using [
Topics: Arteries; Atherosclerosis; Copper Radioisotopes; Heterocyclic Compounds, 1-Ring; Humans; Oligopeptides; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Receptors, Urokinase Plasminogen Activator; Retrospective Studies; Urokinase-Type Plasminogen Activator | 2022 |